Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

82-44-0

1-Chloro anthraquinone

82-44-0
82-46-2

1,5-Dichloroanthraquinone

82-46-2
54029-12-8

Albendazole Sulfoxide

54029-12-8
6521-29-5

Amyl 4-Hydroxybenzoate

6521-29-5
80983-34-2

Albendazole Amino Sulfone

80983-34-2
09/05/2804

Azaperol

09/05/2804
1501-84-4

Rimantadine HCl

1501-84-4
104075-48-1

Atipamezole HCl

104075-48-1
82050-13-3

2-Aminoflubendazole

82050-13-3
26787-78-0

Amoxicillin

26787-78-0
314-19-2

Apomorphine HCl

314-19-2
129722-12-9

Aripiprazole

129722-12-9
23964-58-1

Articaine

23964-58-1
1074549-89-5

Apixaban 4,5-Dehydro

1074549-89-5
23964-57-0

Articaine HCl

23964-57-0
616-91-1

Acetylcysteine

616-91-1
850140-72-6

Afatinib

850140-72-6
319460-85-0

Axitinib

319460-85-0
134523-03-8

Atorvastatin calcium salt

134523-03-8
26116-12-1

2-(Aminomethyl)-1-ethylpyrrolidine

26116-12-1